Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials

DSpace/Manakin Repository

Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials

Citable link to this page

 

 
Title: Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials
Author: Beca, Francisco; Beck, Andrew H.

Note: Order does not necessarily reflect citation order of authors.

Citation: Beca, Francisco, and Andrew H. Beck. 2016. “Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.” PLoS Medicine 13 (12): e1002177. doi:10.1371/journal.pmed.1002177. http://dx.doi.org/10.1371/journal.pmed.1002177.
Full Text & Related Files:
Abstract: In a Perspective, Francisco Beca and Andrew Beck discuss Charles Swanton and colleagues' accompanying Research Article on somatic mutations in patients with inflammatory breast cancer treated in a Phase II clinical trial.
Published Version: doi:10.1371/journal.pmed.1002177
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140044/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:29738944
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters